Real-time enrollment status for this glioblastoma who grade iv clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 12:37 PM UTC
| NCT Number | NCT06883747 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma WHO Grade IV |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nader Sanai |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 22, 2026: Clinical trial NCT06883747 is currently recruiting participants. This early_phase1 study for glioblastoma who grade iv is actively seeking new participants at 1 location across the United States. The study is sponsored by Nader Sanai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06883747 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06883747 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.